Heart Disease and Stroke Statistics—2016 Update
Author(s): Writing Group Members; Mozaffarian, Dariush; Benjamin, Emelia J; Go, Alan S; Arnett, Donna K; Blaha, Michael J; Cushman, Mary; Das, Sandeep R; de Ferranti, Sarah; Des...
Publications
Explore 1,882 academic publications
Showing 12 of
1,882 publications
The bactericidal effect of silver nanoparticles
Nanotechnology is expected to open new avenues to fight and prevent disease using atomic scale tailoring of materials. Among the most promising nanomaterials with antibacterial ...
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence...
Beyond Cholesterol
IT is now well established that hypercholesterolemia is an important cause of coronary heart disease, and clinical intervention studies have demonstrated the therapeutic value o...
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
Abstract Aims To establish a unified working diagnostic tool for the metabolic syndrome (MetS) that is convenient to use in clinical practice and that can be used world‐wide so ...
Validation of a combined comorbidity index
The basic objective of this paper is to evaluate an age-comorbidity index in a cohort of patients who were originally enrolled in a prospective study to identify risk factors fo...
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
OBJECTIVE To estimate the prevalence of diabetes and the number of people with diabetes who are ≥20 years of age in all countries of the world for three points in time, i.e., th...
2016 European Guidelines on cardiovascular disease prevention in clinical practice
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at \nthe t...
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through ...
Prevalence and Trends in Obesity Among US Adults, 1999-2000
The increases in the prevalences of obesity and overweight previously observed continued in 1999-2000. The potential health benefits from reduction in overweight and obesity are...